文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

脓毒症诱导的心肌病与死亡率的相关性:系统评价与荟萃分析

Association of sepsis-induced cardiomyopathy and mortality: a systematic review and meta-analysis.
PubMed 文献 · Ann Intensive Care · 2022-12-13
一句话结论荟萃分析显示脓毒症诱导的心肌病与1个月死亡率升高相关(RR 1.47),右心室功能障碍与1个月死亡率升高相关(RR 1.72)。

该系统评价与荟萃分析检索PubMed和Embase截至2021年7月8日的观察性研究,纳入20项研究、4410例脓毒症患者,采用随机效应模型分析脓毒症诱导的心肌病(SIC)与院内及1个月死亡率的关系。结果显示SIC与院内死亡率升高无统计学关联(RR 1.28,[0.96-1.71];p=0.09),但在住院时长超过10天的患者中关联有统计学意义(RR 1.40,[1.02-1.93];p=0.04);SIC与1个月死亡率升高显著相关(RR 1.47,[1.17-1.86];p<0.01)。SIC患者中右心室功能障碍与1个月死亡率升高显著相关(RR 1.72,[1.27-2.34];p<0.01),左心室功能障碍则无统计学关联(RR 1.33,[0.87-2.02];p=0.18)。作者认为SIC可能在心肌病恢复后仍持续影响宿主系统,右心室功能障碍可能在SIC相关死亡中起关键作用,及时的双心室评估对脓毒症患者管理至关重要。

要点

  • SIC与1个月死亡率升高显著相关(RR 1.47,[1.17-1.86];p<0.01),纳入20项研究、4410例脓毒症患者。
  • SIC与院内死亡率升高无统计学关联(RR 1.28,[0.96-1.71];p=0.09)。
  • 住院时长超过10天的患者中,SIC与院内死亡率升高相关(RR 1.40,[1.02-1.93];p=0.04)。
  • SIC患者中右心室功能障碍与1个月死亡率升高显著相关(RR 1.72,[1.27-2.34];p<0.01)。
  • SIC患者中左心室功能障碍与1个月死亡率无统计学关联(RR 1.33,[0.87-2.02];p=0.18)。

适用人群与场景

  • 脓毒症患者(20项观察性研究,共4410例)
  • 亚组:住院时长超过10天的脓毒症患者
  • 亚组:合并右心室功能障碍或左心室功能障碍的SIC患者

研究设计与关键结果

  • 研究类型:系统评价与荟萃分析,纳入20项观察性研究、4410例脓毒症患者,检索PubMed和Embase自建库至2021年7月8日。
  • 主要终点:SIC与非SIC相比院内死亡率无统计学显著差异(RR 1.28,[0.96-1.71];p=0.09)。
  • 亚组:住院时长超过10天的患者中,SIC与院内死亡率升高相关(RR 1.40,[1.02-1.93];p=0.04)。
  • SIC与1个月死亡率升高显著相关(RR 1.47,[1.17-1.86];p<0.01)。
  • SIC患者中,右心室功能障碍与1个月死亡率升高显著相关(RR 1.72,[1.27-2.34];p<0.01)。
  • SIC患者中,左心室功能障碍与1个月死亡率无统计学关联(RR 1.33,[0.87-2.02];p=0.18)。

证据类型、等级与局限

  • 证据类型:系统评价与荟萃分析,纳入观察性研究。
  • 采用随机效应模型;应用Meta回归、亚组和敏感性分析检验异质性。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,SIC可能在心肌病恢复后仍持续影响宿主系统,因住院超过10天者院内死亡率更高且1个月死亡率更高。
  • 作者认为,右心室功能障碍可能在SIC相关死亡中起关键作用,及时的双心室评估对脓毒症患者管理至关重要。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The implication of sepsis-induced cardiomyopathy (SIC) to prognosis is controversial, and its association with mortality at different stages remains unclear. We conducted a systematic review and meta-analysis to understand the association between SIC and mortality in septic patients.

METHODS: We searched and appraised observational studies regarding the mortality related to SIC among septic patients in PubMed and Embase from inception until 8 July 2021. Outcomes comprised in-hospital and 1-month mortality. We adopted the random-effects model to examine the mortality risk ratio in patients with and without SIC. Meta-regression, subgroup, and sensitivity analyses were applied to examine the outcome's heterogeneity.

RESULTS: Our results, including 20 studies and 4,410 septic patients, demonstrated that SIC was non-statistically associated with increased in-hospital mortality, compared to non-SIC (RR 1.28, [0.96-1.71]; p = 0.09), but the association was statistically significant in patients with the hospital stay lengths longer than 10 days (RR 1.40, [1.02-1.93]; p = 0.04). Besides, SIC was significantly associated with a higher risk of 1-month mortality (RR 1.47, [1.17-1.86]; p < 0.01). Among SIC patients, right ventricular dysfunction was significantly associated with increased 1-month mortality (RR 1.72, [1.27-2.34]; p < 0.01), while left ventricular dysfunction was not (RR 1.33, [0.87-2.02]; p = 0.18).

CONCLUSIONS: With higher in-hospital mortality in those hospitalized longer than 10 days and 1-month mortality, our findings imply that SIC might continue influencing the host's system even after recovery from cardiomyopathy. Besides, right ventricular dysfunction might play a crucial role in SIC-related mortality, and timely biventricular assessment is vital in managing septic patients.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Lin YM, Lee MC, Toh HS, et al. Association of sepsis-induced cardiomyopathy and mortality: a systematic review and meta-analysis. Ann Intensive Care. 2022. PMID: 36513882. doi:10.1186/s13613-022-01089-3

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。